GL1X · GenesisL1 explorer

Research workbench

Bace crystal structure with hydroxy pyrrolidine inhibitor

Analyse Bace crystal structure with hydroxy pyrrolidine inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6BFE
Type
protein
Length
782 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
DJV
Pockets
4 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 15% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein39316% helix, 39% strandP56817
BBeta-secretase 1 (EC 3.4.23.46)protein38915% helix, 39% strandP56817

Ligands and binding sites

  • DJV · N-[(1R,2S)-1-[(2R,4R)-4-(cyclohexylmethoxy)pyrrolidin-2-yl]-3-(3,5-difluorophenyl)-1-hydroxypropan-2-yl]acetamide · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17970.770.8173GOL
23100.690.8347DJV
32900.670.8342DJV, GOL
4910.550.8525empty

Interfaces

1 interface between chains.

  • A–B · 477 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 6BFE · BACE crystal structure with hydroxy pyrrolidine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.